Headlines discussed at LNWM’s Monday morning briefing:
— The U.S. Congress is set to approve nearly $900 billion in Covid-19 aid, after $2.3 trillion in March, as part of a $1.4 trillion spending bill to fund the federal gov’t through Sept. 2021.
— Major European countries banned travel from a locked-down U.K. on concerns about a more contagious strain of Covid-19 still being researched.
— The FDA approved a second Covid-19 vaccine, this one by Moderna; distribution began Sunday, Dec. 20.
— U.S. retail sales fell 1.1% in Nov. after a 0.1% decline in Oct., amid falling household income and raging Covid-19 infections.
— The Federal Reserve loosened restrictions on bank stock buybacks; limited to average net income over 4 latest quarters.
Disclaimer: Clicking on any of the above links will take you away from the Laird Norton Wealth Management web page and to the source page. While we believe the information in these articles is relevant, we cannot guarantee its accuracy or completeness.